-+ 0.00%
-+ 0.00%
-+ 0.00%

MAXONA PHARMACEUTICALS RECEIVES FDA IND CLEARANCE FOR MAX-001 PHASE 2 ACUTE PAIN CLINICAL TRIAL

Reuters·07/15/2026 12:00:46

Please log in to view news